Language

News topic

ATC group N05AH03

Current shortage notices for the ATC group N05AH03, structured by product, country and reporting period.

50 notices

← All shortages

What the N05AH03 notices indicate for the supply chain

The 50 consolidated notices from Germany, Austria, Belgium, Czechia are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Austria

ZYPADHERA 405 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension

Active ingredient: OLANZAPIN

View notice details →
Austria

ZYPADHERA 300 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension

Active ingredient: OLANZAPIN

View notice details →
Belgium

Olanzapine EG 7.5 mg film-coat. tabl. 98

Active ingredient: Olanzapine

View notice details →
Belgium

Olanzapine EG 10 mg film-coat. tabl. 98

Active ingredient: Olanzapine

View notice details →
Belgium

Olanzapine Sandoz 7.5 mg film-coat. tabl. 100

Active ingredient: Olanzapine

View notice details →
Belgium

Olanzapine EG 7.5 mg film-coat. tabl. 98

Active ingredient: Olanzapine

View notice details →
Belgium

Olanzapine EG 10 mg film-coat. tabl. 98

Active ingredient: Olanzapine

View notice details →
Austria

Olanzapin 1A Pharma 5 mg - Filmtabletten

Active ingredient: OLANZAPIN

View notice details →
Austria

Olanzapin neuraxpharm 10 mg Schmelztabletten

Active ingredient: OLANZAPIN

View notice details →
Germany

Olanzapin Glenmark 20 mg Tabletten - OP70

Active ingredient: Olanzapin

View notice details →
Germany

Olanzapin Glenmark 2,5 mg Tabletten - OP70

Active ingredient: Olanzapin

View notice details →
Germany

Olanzapin Glenmark 2,5 mg Tabletten - OP56

Active ingredient: Olanzapin

View notice details →
Belgium

Zypadhera 405 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 405 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 300 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 300 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 210 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 210 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Germany

ZYPADHERA 405 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(931mg+3ml)

Active ingredient: Olanzapinembonat-Monohydrat

View notice details →
Germany

ZYPADHERA 300 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(690mg+3ml)

Active ingredient: Olanzapinembonat-Monohydrat

View notice details →
Czechia

OLANZAPIN ACTAVIS 10MG POR TBL DIS 56 II

Active ingredient: OLANZAPIN

View notice details →
Germany

OLANZAPIN BASICS 15 mg Schmelztabletten

Active ingredient: Olanzapin

View notice details →
Czechia

OLANZAPIN ACTAVIS 10MG POR TBL DIS 28 II

Active ingredient: OLANZAPIN

View notice details →
Belgium

Olanzapine Sandoz 10 mg film-coat. tabl. 100

Active ingredient: Olanzapine

View notice details →
Austria

Olanzapin 1A Pharma 10 mg - Filmtabletten

Active ingredient: OLANZAPIN

View notice details →
Belgium

Zypadhera 405 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 405 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 300 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 300 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 210 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 210 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Olanzapine Sandoz 7.5 mg film-coat. tabl. 100

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 405 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 405 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 300 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 300 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 210 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 210 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Germany

ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml)

Active ingredient: Olanzapinembonat-Monohydrat

View notice details →
Belgium

Zypadhera 405 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 405 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 300 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 300 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Belgium

Zypadhera 210 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 210 mg + 3 ml

Active ingredient: Olanzapine

View notice details →
Austria

Olanzapin 1A Pharma 5 mg - Filmtabletten

Active ingredient: OLANZAPIN

View notice details →
Austria

Olanzapin Actavis 15 mg Schmelztabletten

Active ingredient: OLANZAPIN

View notice details →
Austria

Olanzapin Actavis 5 mg Schmelztabletten

Active ingredient: OLANZAPIN

View notice details →
Germany

ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension

Active ingredient: Olanzapinembonat-Monohydrat

View notice details →
Germany

Olanzapin Glenmark 2,5 mg Tabletten - OP70

Active ingredient: Olanzapin

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.